Triazoles demonstrate multi-target enzyme inhibition, advancing broad-spectrum antimicrobial drug design.

The escalating global crisis of antimicrobial resistance necessitates novel therapeutic strategies. Current antimicrobial agents often face limitations due to evolving resistance mechanisms, creating an urgent demand for multi-target directed ligands. Triazoles, a distinct class of heterocycles, are being extensively studied for their ability to inhibit multiple key microbial enzymes, offering a promising avenue to overcome resistance and develop broad-spectrum antimicrobials.

This review synthesizes current literature on triazoles as enzyme inhibitors, focusing on synthetic advancements, mechanisms of action, and structure-activity relationships. It correlates experimental findings with computational insights, including molecular docking studies, to elucidate binding affinities and inhibitory potential. The paper explores innovative synthetic routes, such as molecular hybridization, that have diversified the triazole scaffold for enhanced therapeutic efficacy.

Triazoles demonstrate significant multi-target inhibitory potential against various microbial enzymes. As antifungals, they primarily inhibit lanosterol 14α-demethylase (CYP51), a crucial enzyme in fungal ergosterol biosynthesis. For antibacterial activity, triazoles target key bacterial enzymes including DNA gyrase, dihydrofolate reductase (DHFR), peptide deformylase (PDF), enoyl-ACP reductase (FabI), and various RNA-associated enzymes, effectively disrupting essential microbial pathways. Computational molecular docking studies revealed that triazole derivatives generally produced more favorable docking scores compared to kojic acid when modeled against Bacillus megaterium TYR.

These docking studies highlighted recurring interactions with critical hydrophobic residues such as Met215, Val217, Ala221, and Phe227, alongside hydrogen-bonding contacts with Gly216, elucidating the molecular basis for their inhibitory action. The review emphasizes that recent synthetic advancements, including molecular hybridization, enable the creation of structurally diverse triazole derivatives with improved inhibitory potential and selectivity.